Assessing The effect of provision of information on patient anxiety and comfort in Extracorporeal Shock Wave Lithotripsy

Assessing The effect of provision of information by video and lecture before Extracorporeal Shock Wave Lithotripsy on patient anxiety and comfort

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200827048546N1

Enrollment

122

Registered

2020-09-06

Start date

2020-10-22

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Urinary tract stones. Condition 2: Extracorporeal Shock Wave Lithotripsy. Condition 3: Anxiety. Condition 4: Comfort. Condition 5: Cortisol. Condition 6: Physiological indicators. Urinary calculus, unspecified Anxiety disorder due to known physiological condition

Interventions

Intervention 1: Intervention group: To the intervention group in order to inform before the operation, in the morning of the operation Researcher With face-to-face speeches in groups of 3-4 in the c

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patient with urinary stone Disease and ESWL candidate Willingness to cooperate in the project Ages 18 to 65 years The first experience of ESWL Ability to read and write No membership in the treatment team Lack of vision and hearing problems Do not take medications that reduce or increase cortisol like Corticosteroids, anticonvulsants, insulin Do not use sedatives and anti-anxiety drugs before the intervention

Exclusion criteria

Exclusion criteria: Any patient dissatisfaction during the research Any acute problems at the time of the study

Design outcomes

Primary

Measure	Time frame
Anxiety score in Spielberger's anxiety questionnaire. Timepoint: Completion of the questionnaire before the intervention and after the awareness. Method of measurement: Spielberger Anxiety Questionnaire.;Measuring anxiety with salivary cortisol levels. Timepoint: Before the intervention and after the awareness. Method of measurement: Saliva sample in the amount of 3 to 5 cc.;Anxiety level by measuring the number of breaths, pulse rate and blood pressure. Timepoint: Before the intervention and after the awareness. Method of measurement: Count the number of breaths and pulses per minute And measuring blood pressure with a mercury sphygmomanometer.;Comfort score on the Kolkaba General Comfort Questionnaire. Timepoint: Before the intervention and after the awareness. Method of measurement: Kolkaba General Comfort Questionnaire.	—

Measure

Time frame

Anxiety score in Spielberger's anxiety questionnaire. Timepoint: Completion of the questionnaire before the intervention and after the awareness. Method of measurement: Spielberger Anxiety Questionnaire.;Measuring anxiety with salivary cortisol levels. Timepoint: Before the intervention and after the awareness. Method of measurement: Saliva sample in the amount of 3 to 5 cc.;Anxiety level by measuring the number of breaths, pulse rate and blood pressure. Timepoint: Before the intervention and after the awareness. Method of measurement: Count the number of breaths and pulses per minute And measuring blood pressure with a mercury sphygmomanometer.;Comfort score on the Kolkaba General Comfort Questionnaire. Timepoint: Before the intervention and after the awareness. Method of measurement: Kolkaba General Comfort Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeedeh Azizi Mahkooyeh

Tehran University of Medical Sciences

saeedeh.azizi2013@gmail.com0098 21 09307549330

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026